If you were prescribed an angiotensin-converting enzyme inhibitor
, angiotensin receptor blocker, beta-blocker or diuretic, your doctor may have explained that the drug needs to be titrated.
Agostoni, "Angioedema associated with angiotensin-converting enzyme inhibitor
use: outcome after switching to a different treatment," Archives of Internal Medicine, vol.
Studdiford, "Angioedema after local trauma in a patient on angiotensin-converting enzyme inhibitor
therapy," The Journal of the American Board of Family Medicine, vol.
Dipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor
Chalmers' analysis used data from an average 6-year follow-up of patients after they completed a 4-year trial that had randomized them to treatment with either the combined formulation of the angiotensin-converting enzyme inhibitor
perindopril and the diuretic indapamide, or to placebo.
One of the four guideline recommendations speaking to this issue is that the ACP "recommends against testing for proteinuria in adults with or without diabetes who are currently taking an angiotensin-converting enzyme inhibitor
or an angiotensin II-receptor blocker." Reviewed evidence suggests that ACE inhibitors or ARBs reduce the risk for end-stage renal disease and that there is no evidence that monitoring for proteinuria in patients on these medications improves outcomes for patients with chronic kidney disease (CKD).
Hypotensive reactions to white cell-reduced plasma in a patient undergoing angiotensin-converting enzyme inhibitor
Adults assigned to drugs alone were prescribed similar treatments, which included aspirin, a statin, a [beta]-blocker, and an angiotensin-converting enzyme inhibitor
. Four-fifths of the participants were men.
The actual ingredients are an angiotensin-converting enzyme inhibitor
(ramipril 5 mg), a beta-blocker (atenolol 50 mg), a diuretic (hydrochlorothiazide 12.5 mg), the statin simvastatin 20 mg, and aspirin 100 mg.
Angiotensin-converting enzyme inhibitor
induced syndrome of inappropriate secretion of antidiuretic hormone: case report and review of the literature.
Cardiorenal protective effects of yearlong antihypertensive therapy with a angiotensin-converting enzyme inhibitor
or a calcium channel blocker in spontaneously hypertensive rat.